This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Menu
Book
Key Sessions
Antonio Lanzavecchia, M.D
Mechanisms of Antibody-mediated Resistance to Infectious Diseases
National Institute of Molecular Genetics
June 9 - Live Sessionskeyboard_arrow_right

June 9 - Live Sessions - BST (British Summer Time, GMT+1)

keyboard_arrow_leftSearch & Filter
search

June 9 - Live Sessions - BST (British Summer Time, GMT+1)

search
June 9 - Live Sessions 09:45 - 10:1530 mins
Scientific Briefing
    June 9 - Live Sessions 10:30 - 11:0030 mins
    Scientific Briefing
    Are Unvalidated Antibodies Undermining Your Research?
    • Monique Seymour - Scientific Sales Executive, Rapid Novor
    June 9 - Live Sessions 11:15 - 12:1560 mins
    Keynote Presentation with Introduction by Session Chair
    Mechanisms of Antibody-mediated Resistance to Infectious Diseases
    • Antonio Lanzavecchia, M.D - Invernizzi Fellow, Human Immunology Program, National Institute of Molecular Genetics
    To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
    June 9 - Live Sessions 12:30 - 13:1545 mins
    Live Panel Discussion & Speaker Q&A
    Advances in T-Cell Engaging Therapies
    • Kerry Chester, PhD - Professor of Molecular Medicine, UCL Cancer Institute
    • Christian Klein, PhD - Head Oncology Programs, Roche Innovation Center Zurich
    • Roeland Lameris, M.D. - Resident Internal Medicine and PhD Student, Amsterdam UMC
    • Paul Hughes, Ph.D. - Scientific Director, Amgen
    • Nadine van Montfoort , Ph.D. - Assistant Professor and Group Leader, Leiden University Medical Centre
    • Stephen Russell, M.D., Ph.D. - Professor of Molecular Medicine, Mayo Clinic
    • Gernot Stuhler, MD - Immunotherapy Lab, University Hospital Würzburg
    June 9 - Live Sessions 14:15 - 14:4530 mins
    Scientific Briefing
    Uncovering Critical Receptors and Assessing Target Specificity of Biotherapeutics
    • Diogo Rodrigues Ferreirinha - European Business Development Manager, Retrogenix Limited
    June 9 - Live Sessions 15:00 - 15:3030 mins
    Scientific Briefing
    Amplifying Antibody Diversity with Single-cell Screening and Immune Repertoire Sequencing
    • Kevin Heyries, Ph.D. - Co-founder & Head of Business Development, AbCellera
    To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
    June 9 - Live Sessions 15:45 - 16:3045 mins
    Live Panel Discussion & Speaker Q&A
    Payloaded Antibodies and Immune-oncology – Crossroads
    • Esther Breij, PhD - Senior Director, Translational Research, Genmab BV
    • Francesca Zammarchi, PhD - Head of Pharmacology, ADC Therapeutics
    • Sara Mangsbo, PhD - Senior Associate Lecturer, Uppsala University
    • Betsy Gray, Ph.D. - Senior Scientist, Immunology, Seagen
    • Myriam Fabre, Ph.D. - R&D Director, Oncomatryx Biopharma S.L.
    • Michael Alonso, Ph.D. - Vice President, Immunology and Pharmacology, Bolt Biotherapeutics
    June 8 - Live Sessions
    NextJune 10 - Live Sessions
    Filter
    Streams
    Formats
    Choose Day